EUVIMEDEUVIMED entdecken
Crossref

Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple‐Modal Therapy on Tumors

Xiaobing Du, Guangbo Kang, Lina Wang, Zhichao Gong, Xu Jiang, Jiachen Pan, Xiaoying Li, Danping Zhang, He Huang, Shuxian Meng iD

Small · 2026

DOI: 10.1002/smll.202511296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Xiaobing Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, P. R. China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Escherichia coli, Neoplasms. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Key Research and Development Project, Tianjin Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteria‐mediated cancer therapy offers great promise for tumor targeting and immune activation but faces challenges of limited potency and biosafety. Here, a reinforced platform, E@PB, is developed by coating E. coli Nissle 1917 with polydopamine (PDA) and a cationic BODIPY‐based photosensitizer (BOD‐QAS). This dual‐photosensitized system integrates photothermal and photodynamic modalities while maintaining bacterial viability. The PDA coating enhances tumor colonization and immune stimulation through 808 nm laser‐induced hyperthermia, whereas BOD‐QAS enables 660 nm‐triggered reactive oxygen species generation for tumor cell apoptosis and bacterial growth regulation. The photosensitizer shell also provides real‐time fluorescence imaging, improving therapeutic precision. A two‐stage “green‐to‐red light” strategy allows spatiotemporal control of bacterial activity, maximizing both efficacy and safety. E@PB accumulates rapidly at tumor sites within 8 h and remains for extended periods, enabling sustained therapeutic action. In vivo evaluation demonstrates an 89.8% reduction in tumor volume, highlighting the potential of this triple‐modal system to synergize phototherapy and immune activation in bacteria‐based cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsEscherichia coliNeoplasmsAnimalsHumansIndolesPhotochemotherapyMicePolymersCell Line, TumorReactive Oxygen SpeciesBoron CompoundsCombined Modality Therapy

Stichwörter der Autor:innen

bacterial targetingbiohybridflexible regulationoptical propertiesphototherapyprobiotics

Substanzen

Photosensitizing AgentsIndolespolydopaminePolymersReactive Oxygen SpeciesBoron Compounds

Autor:innen und Institutionen

  • School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, P. R. China.
  • School of Synthetic Biology and Biomanufacturing, State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin Key Laboratory of Biological and Pharmaceutica…
  • Oilfield Chemical R&D Institute, China Oilfield Services Co., Ltd., Tianjin, 300459, P. R. China.

ORCID-Profile: Shuxian Meng

Förderung

  • National Key Research and Development Project
  • Tianjin Science and Technology Planning Project

Zitieren

APA

Du, X., Kang, G., Wang, L., Gong, Z., Jiang, X., Pan, J., Li, X., Zhang, D., Huang, H., & Meng, S. (2026). Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple‐Modal Therapy on Tumors. Small. https://doi.org/10.1002/smll.202511296

Vancouver

Du X, Kang G, Wang L, Gong Z, Jiang X, Pan J, et al. Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple‐Modal Therapy on Tumors. Small. 2026. doi:10.1002/smll.202511296

BibTeX
@article{Du2026,
  author = {Du, Xiaobing and Kang, Guangbo and Wang, Lina and Gong, Zhichao and Jiang, Xu and Pan, Jiachen and Li, Xiaoying and Zhang, Danping and Huang, He and Meng, Shuxian},
  title = {Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple‐Modal Therapy on Tumors},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202511296}
}
Kostenlos starten →